Teladoc Health, Inc. shares fall 1.65% intraday as healthcare sector faces broad challenges.

Teladoc Health, Inc. declined 1.65% in intraday trading, with the broader healthcare sector experiencing a downturn. The US Justice Department's requirement for broad divestitures to resolve challenges to UnitedHealth's acquisition of Amedisys, along with the S&P 500 healthcare sector's 5% year-to-date decline, contributed to the negative sentiment. Additionally, the sector's valuation discount to the S&P 500 being nearly the widest in 30 years and Trump administration policies on pharma tariffs and drug pricing further clouded the outlook for healthcare stocks.